Biomea Fusion, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Three
Biomea Fusion, Inc. (BMEA) had Lessee, Operating Lease, Liability, to be Paid, Year Three of $1.44 million as of 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree · last filed 2025-03-31
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Three $1.44M.
- 2024-03-31: Lessee, Operating Lease, Liability, to be Paid, Year Three $1.44M.
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Three $1.38M.
- 2023-09-30: Lessee, Operating Lease, Liability, to be Paid, Year Three $1.38M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year Three |
|---|---|
| 2024-12-31 | $1.44M 10-K · filed 2025-03-31 |
| 2024-03-31 | $1.44M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $1.38M 10-K · filed 2024-03-28 |
| 2023-09-30 | $1.38M 10-Q · filed 2023-10-30 |
| 2023-06-30 | $1.38M 10-Q · filed 2023-07-31 |
| 2023-03-31 | $1.38M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $771.00K 10-K · filed 2023-03-28 |
| 2022-09-30 | $771.00K 10-Q · filed 2022-11-07 |
| 2022-06-30 | $771.00K 10-Q · filed 2022-08-01 |
| 2022-03-31 | $771.00K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $748.00K 10-K · filed 2022-02-28 |
| 2021-09-30 | $748.00K 10-Q · filed 2021-11-03 |
| 2021-06-30 | $748.00K 10-Q · filed 2021-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B |